152 related articles for article (PubMed ID: 7539733)
1. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase.
Lin PJ; Chang CH; Chang JP
Chest; 1994 Aug; 106(2):626-9. PubMed ID: 7539733
[TBL] [Abstract][Full Text] [Related]
2. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
[TBL] [Abstract][Full Text] [Related]
3. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
Petros A; Bennett D; Vallance P
Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
[TBL] [Abstract][Full Text] [Related]
4. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
Schilling J; Cakmakci M; Bättig U; Geroulanos S
Intensive Care Med; 1993; 19(4):227-31. PubMed ID: 7690053
[TBL] [Abstract][Full Text] [Related]
5. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.
Kilbourn RG; Jubran A; Gross SS; Griffith OW; Levi R; Adams J; Lodato RF
Biochem Biophys Res Commun; 1990 Nov; 172(3):1132-8. PubMed ID: 2244897
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
Klemm P; Thiemermann C; Winklmaier G; Martorana PA; Henning R
Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
[TBL] [Abstract][Full Text] [Related]
8. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.
Wolfe TA; Dasta JF
Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
Nava E; Palmer RM; Moncada S
Lancet; 1991 Dec 21-28; 338(8782-8783):1555-7. PubMed ID: 1683974
[TBL] [Abstract][Full Text] [Related]
10. Is endotoxin-induced hypotension related to nitric oxide formation?
Preiser JC; Zhang H; Wachel D; Boeynaems JM; Buurman W; Vincent JL
Eur Surg Res; 1994; 26(1):10-8. PubMed ID: 7511103
[TBL] [Abstract][Full Text] [Related]
11. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW
Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
[TBL] [Abstract][Full Text] [Related]
12. [Nitric oxide and sepsis].
Gómez Jiménez J; Salgado Remigio A
Med Clin (Barc); 1993 Dec; 101(19):741-2. PubMed ID: 7507194
[No Abstract] [Full Text] [Related]
13. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.
Kilbourn RG; Fonseca GA; Griffith OW; Ewer M; Price K; Striegel A; Jones E; Logothetis CJ
Crit Care Med; 1995 Jun; 23(6):1018-24. PubMed ID: 7774211
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of nitric oxide in cytokine-mediated and septic shock.
Kilbourn RG; Griffith OW
J Natl Cancer Inst; 1992 Jun; 84(11):827-31. PubMed ID: 1375655
[No Abstract] [Full Text] [Related]
15. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock.
Klabunde RE; Coston AF
Shock; 1995 Jan; 3(1):73-8. PubMed ID: 7531606
[TBL] [Abstract][Full Text] [Related]
16. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
17. Cyclic nucleotides and vasoactive intestinal peptide production in a rabbit model of Escherichia coli septicemia.
Broner CW; O'Dorisio MS; Rosenberg RB; O'Dorisio TM
Am J Med Sci; 1995 May; 309(5):267-77. PubMed ID: 7537447
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhibition of nitric oxide synthase in acute renal failure due to endotoxin shock in dogs.
Papadimitriou M; Economidou D; Vakianis P; Raidis C; Vrettos M; Margari P; Leontsini M
Nephrol Dial Transplant; 1994; 9 Suppl 4():82-7. PubMed ID: 7528366
[No Abstract] [Full Text] [Related]
19. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.
Cobb JP; Natanson C; Hoffman WD; Lodato RF; Banks S; Koev CA; Solomon MA; Elin RJ; Hosseini JM; Danner RL
J Exp Med; 1992 Oct; 176(4):1175-82. PubMed ID: 1383377
[TBL] [Abstract][Full Text] [Related]
20. Effects of nitric oxide synthase inhibitor on hemodynamic change and O2 delivery in septic dogs.
Mitaka C; Hirata Y; Ichikawa K; Uchida T; Yokoyama K; Nagura T; Tsunoda Y; Amaha K
Am J Physiol; 1995 May; 268(5 Pt 2):H2017-23. PubMed ID: 7539593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
